Last updated: June 7, 2026
DOXY 200 (doxycycline 200 mg) suppliers: Who manufactures and distributes 200 mg doxycycline products?
Who are the suppliers for DOXY 200 (doxycycline 200 mg) in the market?
If DOXY 200 is sold as a specific branded product, supplier lists depend on the jurisdiction and the exact marketing authorization (MA) tied to that brand. Without the country/MA identifier and the specific dosage form (immediate-release tablets, capsules, modified release, or suspension), a definitive supplier set cannot be produced.
What companies make doxycycline 200 mg products (tablets/capsules) globally?
Global manufacturing for “doxycycline 200 mg” typically spans:
- Originator and licensing supply chains (manufacturing outsourced to contract manufacturers)
- Generic manufacturers producing doxycycline hyclate or doxycycline monohydrate strengths equivalent to 200 mg per unit
- Regional packers and distributors that do not manufacture APIs but supply finished dosage forms
A complete, accurate supplier list requires the exact DOXY 200 formulation and approved label claim, which determines whether the product is doxycycline hyclate or monohydrate and the specific dosage form.
Is DOXY 200 doxycycline hyclate or doxycycline monohydrate, and who supplies each form?
Supplier eligibility for DOXY 200 hinges on the salt form:
- Doxycycline hyclate products are typically manufactured under different DMFs/authorizations than monohydrate equivalents.
- Finished-goods suppliers may differ from API suppliers even when the active moiety is the same.
A definitive mapping from DOXY 200 to hyclate vs monohydrate requires the approved product labeling tied to the specific DOXY 200 brand.
What are the API suppliers for doxycycline used in 200 mg products?
Doxycycline APIs are sourced from multiple global producers and traders, with downstream finished-goods manufacturers sourcing APIs via:
- Approved DMF/API qualification pipelines
- Contract supply agreements
- Regional distributors
A concrete “API supplier” list for DOXY 200 requires the drug master file reference(s) or API manufacturer name on the approved finished product dossier, which is not provided.
Which distributors supply DOXY 200 (200 mg doxycycline) to pharmacies and hospitals?
Distribution is usually performed by:
- Wholesalers with regional coverage
- Hospital procurement suppliers
- Importers/parallel distributors where permitted
But DOXY 200’s distributor set is country-specific and depends on the MA holder and channel structure for that brand.
What regulatory filings identify the DOXY 200 manufacturer (country-specific)?
For supply chain certainty, manufacturing identifiers come from:
- FDA Orange Book or Drugs@FDA entries (if in the US)
- EMA EPAR and national MA registers (EU)
- National medicine agency registries in each country
No MA identifier or jurisdiction is provided, so manufacturing attribution cannot be stated accurately.
How do suppliers differ by dosage form for “doxycycline 200 mg” products?
“Doxycycline 200 mg” can appear as different dosage forms, each with different manufacturing lines:
- Tablets vs capsules vs suspensions
- Immediate-release vs any modified-release formats
Supplier attribution varies by dosage form even if the strength is 200 mg.
Key Takeaways
- “DOXY 200” supply chain attribution is not uniquely determinable without the jurisdiction, dosage form, and exact active ingredient salt (doxycycline hyclate vs monohydrate).
- API and finished-goods suppliers for doxycycline 200 mg often differ, with wholesalers and packers further complicating “supplier” lists.
- A defensible supplier set must be anchored to the specific marketed MA entry for DOXY 200 in a defined country.
FAQs
- Does DOXY 200 always contain doxycycline hyclate at 200 mg?
- How can I identify the manufacturer of a branded doxycycline 200 mg product from the package label?
- Are DOXY 200 suppliers the same across countries for the same brand name?
- Which documents show the API manufacturer for doxycycline 200 mg finished products?
- Do contract manufacturing sites change supplier status year to year for doxycycline products?
References
- ICH. Guidance for Industry: Q6B Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. International Council for Harmonisation, current version.
- FDA. Drugs@FDA: Drug Product Labeling. U.S. Food and Drug Administration.
- FDA. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
